restor3d, a leader in 3D printed and personalized orthopedic implants, announced today the successful closing of a $55 million Series A funding round led by private investors, including Summers Value Partners and existing investors, and an additional $15 million in debt financing led by Trinity Capital. This significant investment will drive the company’s growth and innovation in several key areas:
1.) The release of new patient-specific 3D printed implant systems – Consistent with the goal to deliver novel personalized medical solutions, restor3d will introduce new patient-specific implant systems for total ankle and shoulder replacements. And these systems will offer 3D-printed solutions that fit the unique anatomy and pathology of individual patients. For the patient-specific hip and knee portfolios, the company will continue to make product advancements, including a porous press-fit knee enabled by 3D printing of both the tibial and femoral components.
2.) The continued investments in novel 3D printing technologies will expand restor3d’s rapid in-house ‘powder to sterile product’ production environment, offering the capacity to grow the business for many years to come. Along with providing capacity, these investments will also shorten personalized implant delivery times while simultaneously reducing production costs.
3.) To decrease lead times and support continued high growth, restor3d will continue investments in sophisticated software and design automation solutions. And these advancements will speed the company’s case intake and design processes, reduce digital design times, and improve service levels to our surgeons and their patients.
4.) restor3d is committed to advancing medical education/training. And this new funding will enable the expansion of our educational initiatives, offering surgeons and our sales team with comprehensive training on the latest technologies and surgical techniques in orthopedic and reconstructive surgery.
KEY QUOTE:
“This fundraising round is a testament to the confidence our investors have in restor3d’s vision and potential. With this capital, we can accelerate our efforts to transform orthopedic care through 3D printed personalized implants. We are eager to maximize our impact on patient outcomes and continue to advance of orthopedic care. We are grateful for the support from our investors and look forward to a future of continued growth and success.”
“We are thrilled to partner with Trinity as we continue to scale our business and bring our innovative, patient specific medical devices to more surgeons and patients worldwide. This investment underscores the immense potential of our technology to transform patient care and drive better surgical outcomes.”
- CEO Kurt Jacobus
“restor3d is at the forefront of innovation in the customized orthopedic implant industry with its unique patient specific 3D printed technologies. We look forward to working with restor3d’s leadership team and supporting the company’s continued growth.”
- Lauren Cosentino, Managing Director, Life Sciences at Trinity
